OTCBB:AGNPF

Algernon Pharmaceuticals Stock Signals

etoro logo Buy AGNPF
*Your capital is at risk
$0.248
-0.0513 (-17.12%)
At Close: Jul 31, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for Algernon Pharmaceuticals Inc.

General

Signal Type Signal Value Data
Score 0.000 101 days ( 16.90 %
Last Price $0.248 -17.12 %
Performance History
7 Days
$0.293 $0.248
-15.26%
30 Days
$0.299 $0.248
-16.88%
12 Mos
$0.470 $0.248
-47.08%

5/18

Active Buy Signals

Specific Signals

Short Term
Net score: 50
Signal Type Signal Value Importance Data
High / Low Neutral Very Low $0.220 - $0.252
Position: 88.12% from low / 11.88% from high · Momentum: 9.36%
Trend - 3 mos 66.82 % High Width: 150.33 %
Pred. range - 3 mos $0.368 - $0.92 Low 48.26 % - 271.14 %
Volume Direction Buy High Volume: 473 · Direction: 1.00
Pivot Short Sell Very Low Jun 16, 2026 - 32 days
RSI Short Pivot Signal Sell Very Low Jul 29, 2026 - 3 days
Short MA 3 mos Sell Low Jul 30, 2026 - 2 days
Long MA 3 mos Sell Medium Jul 15, 2026 - 13 days
Short/Long MA 3 mos Sell Medium Jun 26, 2026 - 25 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 22.83
Signal Type Signal Value Importance Data
Trend - 12 mos -47.26 % Very High Width: 721.76 %
Pred. range - 12 mos N/A - $0.209 High -100.00 % - -15.90 %
Short MA 12 mos Sell Very High Jul 16, 2026 - 12 days
Long MA 12 mos Sell Very High Jul 30, 2026 - 2 days
Short/Long MA 12 mos Buy Very High Jun 11, 2026 - 35 days
Pivot Long Sell Low Jun 16, 2026 - 32 days
RSI Long Pivot Signal Sell Low Jul 28, 2026 - 4 days
Bollinger Buy Medium Jul 31, 2026 - 1 day
MACD Sell High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT ALGERNON PHARMACEUTICALS INC.
Algernon Pharmaceuticals
Algernon Pharmaceuticals Inc. operates as a clinical stage pharmaceutical development company. It focuses on the areas of non–alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, and acute lung injury associated with COVID-19 in Canada and Australia. The company's lead candidate is NP-120, an N-methyl-d-aspartate (NMDA) receptor glutamate receptor antagonist, which targets N...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE